![Jeffrey Hatfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Hatfield
Chairman at
VIR BIOTECHNOLOGY, INC.
Net worth: 405 623 $ as of 30/06/2026
Profile
Jeffrey S.
Hatfield is currently Chairman at Vividion Therapeutics, Inc. since 2023, Independent Chairman at Vir Biotechnology, Inc. starting in 2026, Chairman at Rome Therapeutics, Inc. since 2022, and Director at Gate Bioscience, Inc. beginning in 2024.
Former roles include President, Chief Executive Officer & Director at Vitae Pharmaceuticals LLC from 2011 to 2016; Chief Executive Officer & Director at Zafgen, Inc. from 2017 to 2020; Chief Executive Officer at Larimar Therapeutics, Inc. from 2017 to 2020; Chairman at Viridian Therapeutics, Inc. from 2018 to 2021; Director at Ambit Biosciences Corp.
from 2014 to 2015; Independent Director at aTyr Pharma, Inc. from 2017 to 2021; Director at Biotechnology Innovation Organization from 2011 to 2016; Director at InVivo Therapeutics Corp.; Independent Director at Invivo Therapeutics Holdings Corp.
from 2016 to 2018; Senior VP-Virology & Immunology Divisions at Bristol Myers Squibb Co. from 2000 to 2004; Vice President at Managed Health Care Associates, Inc.; President & General Manager at Bristol Myers International Group; and President at The Bristol-Myers Squibb Canada Co. Education includes undergraduate studies at Purdue University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/05/2026 | 39,806 ( 0.02% ) | 405 623 $ | 30/06/2026 |
Jeffrey Hatfield active positions
| Companies | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Chairman | 26/05/2026 |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Chairman | 18/07/2022 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Chairman | 24/01/2023 |
Gate Bioscience, Inc.
 Gate Bioscience, Inc. BiotechnologyHealth Technology Develops a small molecule modality to treat biology’s intractable diseases | Director/Board Member | 01/08/2024 |
Former positions of Jeffrey Hatfield
| Companies | Position | End |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Chairman | 01/06/2021 |
| ATYR PHARMA, INC. | Director/Board Member | 28/04/2021 |
| LARIMAR THERAPEUTICS, INC. | Chief Executive Officer | 01/05/2020 |
| LARIMAR THERAPEUTICS, INC. | Chief Executive Officer | 01/05/2020 |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Director/Board Member | 31/12/2018 |
Training of Jeffrey Hatfield
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Health Technology |
Managed Health Care Associates, Inc.
 Managed Health Care Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management and information technology support services to the healthcare industry | Commercial Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Bristol Myers International Group | |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Gate Bioscience, Inc.
Gate Bioscience, Inc. BiotechnologyHealth Technology Develops a small molecule modality to treat biology’s intractable diseases | Health Technology |
- Stock Market
- Insiders
- Jeffrey Hatfield
Choose MarketScreener 
